Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortMakes the body more sensitive to insulin.First-choice tablet for type 2 diabetes.
Body systemDiabetes & WeightDiabetes & Weight
Drug classThiazolidinedionesBiguanides
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesType 2 diabetes, Fatty liver inflammation (MASH, off-label)Type 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label)
How it worksHelps your muscles and fat respond to insulin.Makes your liver release less sugar and helps your body respond to insulin.
Starts working—Blood sugar improves over 1–2 weeks
Half-life3–7 hours (metabolites 16–24 hours)About 6 hours
Typical adult dose15–45 mg once a day.Start 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g).
FormsTablet, Combination tabletsTablet, Modified-release tablet, Oral solution, Combination tablets
Common side effectsWeight gain, Fluid retention, HeadacheDiarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetite
Serious side effectsHeart failure, Bone fractures, Bladder cancer (small possible increase), Macular swellingLactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term use
Don't take if—Severe kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver disease
Alcohol—Best to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar.
PregnancyUsually avoidedNot recommended.Generally considered safeWidely used for gestational and type 2 diabetes in pregnancy.
Breastfeeding—Generally considered safeConsidered acceptable.
In use since19991957
Brand namesUnited States: ActosUnited Kingdom: ActosIndia: Pioz, PiosysUnited States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, Obimet
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BG03A10BA02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker